Ethical Tissue: A Bioresource Specialising in Broad Prospective Supply of Tissue from a Wide Range of Participants
Ethical Tissue (ET) is a Research Tissue Bank specialising in researcher led prospective collection of tissues. ET does not focus on specific conditions nor is it restricted in who it can supply. We consider requests for any type of tissue, including biofluids such as blood, serum, plasma and urine, from researchers in academia or industry from any part of the world. Tissues and biofluids are collected under generic and lasting consent, maximising reuse/sharing potential. ET also provides tissue processing services including tissue micro-arrays from both fresh frozen tissues and FFPE blocks, primary cell cultures, subcellu...
Source: Open Journal of Bioresources - April 8, 2020 Category: Biotechnology Source Type: research

Centre de Ressources Biologiques-Tumoroth èque: Bioresources and Associated Clinical Data Dedicated to Translational Research in Oncology at the Institut de Cancérologie de l’Ouest, France
The Centre de Ressources Biologiques-Tumoroth èque ICO is a biobank integrated in a clinical cancer center (ICO, Institut de Cancérologie de l’Ouest, Saint-Herblain, FR) that collects tissues (snap frozen, FFPE, TMA) and biological (serum, plasma, DNA, RNA, stools, etc) samples from oncology patients and dedicated to translational research. The biobank started its activities in 2002 and is certified NF S 96 900. Activities are framed by a quality management system with established and validated SOPs for all work procedures. Samples stored into the biobank are available for both academic as well as comme...
Source: Open Journal of Bioresources - April 7, 2020 Category: Biotechnology Source Type: research

“CRYOSTEM Biobank: A National Prospective, Standardized Collection to Better Characterize Allogeneic Hematopoietic Stem Cell Transplantation Complications”
CRYOSTEM was initiated in 2010 to create a multicenter biobank in the field of Hematopoietic Stem Cell Transplantation (HSCT). After initially concentrating on Graft-versus-Host Disease, CRYOSTEM has broadened its focus to all HSCT complications. Thanks to a network of 33 transplant units and 23 Biological Resources Centers, CRYOSTEM has established a standardized collection of high-quality biological samples associated with well-annotated clinical data from donors and patients pre- and post-HSCT. Plasma, dried pellets and viable cells in DMSO are isolated and cryopreserved from blood samples. Currently, the collection has...
Source: Open Journal of Bioresources - April 3, 2020 Category: Biotechnology Source Type: research

The Integrated Research Biobank of the University Medicine Greifswald
The Integrated Research Biobank (IRB) at the Institute of Clinical Chemistry and Laboratory Medicine (IKCL) is the central biobank resource of the University Medicine Greifswald (UMG) for all biological materials collected within the framework of clinical and experimental studies carried out by internal and external researchers. The IRB is a core unit of the UMG and focuses on collection, processing and storage of mainly liquid biomaterials, e.g. blood, urine, saliva or swaps in established workflows and thereby securing highest quality standards. Aliquots are usually stored at –80°C in one of the two fully autom...
Source: Open Journal of Bioresources - March 26, 2020 Category: Biotechnology Source Type: research

Interdisciplinary Research on Aortic Valve Stenosis: A Longitudinal Collection of Biospecimens and Clinical Data of Patients Undergoing Transcatheter Aortic Valve Replacement
The bioresource (>265 patients with>27,600 biospecimens until December 2019; recruitment ongoing)  on severe aortic stenosis is of vital importance to improve the still incomplete understanding of its etiology as well as its transition to heart failure. The bioresource contains various biospecimens, standardised clinical and imaging data sets including transthoracic echocardiography, compute d tomography and magnetic resonance imaging of the heart. Biospecimen sampling follows the SOP-driven collection scheme of the German Center for Cardiovascular Research (DZHK) for venous blood and urine [...
Source: Open Journal of Bioresources - March 26, 2020 Category: Biotechnology Source Type: research

The ICAReB Platform: A Human Biobank for the < i > Institut Pasteur < /i > and Beyond
The ICAReB platform of Institut Pasteur provides access to human bio-resources for academic and private research teams worldwide, essentially in the fields of infection, immunity and neurosciences. More than 134,000 human quality controlled, duly annotated samples (mainly whole-blood derived products, but also stool, urine, saliva, swabs ….), from both healthy and diseased cohorts with open, regulated access, are available upon request. Both clinical investigation and biobanking activities are certified following ISO 9001:2015 and NF S96-900:2011 standards, respectively. ICAReB is a member of PIBnet (Pasteur Interna...
Source: Open Journal of Bioresources - March 24, 2020 Category: Biotechnology Source Type: research

An Australian Chronic Kidney Disease Biobank to Support Future Research
The Chronic Kidney Disease (CKD) Biobank is a repository for plasma, erythrocytes, serum, peripheral blood mononuclear cells (PBMCs), DNA, kidney core biopsies, and relevant clinical data. These materials are collected from CKD patients and healthy controls in Queensland, Australia. Plasma, erythrocytes, serum, urine, and PBMCs are collected annually; DNA and kidney core biopsies are one-off collections; and clinical data are updated annually. The CKD Biobank aims to provide domestic investigators associated with the CKD Centre of Research Excellence (CKD.QLD), and international investigators of CKD, with a resource to sup...
Source: Open Journal of Bioresources - May 6, 2019 Category: Biotechnology Source Type: research

Parelsnoer Institute Biobank Hereditary Colorectal Cancer: A Joint Infrastructure for Patient Data and Biomaterial on Hereditary Colorectal Cancer in the Netherlands
Each year approximately 15,000 patients are diagnosed with colorectal cancer (CRC) in the Netherlands, of whom 5 –10% are associated with a hereditary syndrome. To enable future research into hereditary CRC, we established a collaborative biobank for hereditary CRC in all eight University Medical Centers (UMCs) in the Netherlands in 2009. This Biobank Hereditary CRC is part of the Parelsnoer Institute (PSI), which is funded by the Dutch Federation of UMCs and the Dutch Government. Besides the multicenter collaboration, the multidisciplinary nature of this biobank – involving Gastroenterology, Genetics and Surge...
Source: Open Journal of Bioresources - April 25, 2019 Category: Biotechnology Source Type: research

The Quebec Respiratory Health Network Biobank
The Quebec Respiratory Health Network (RHN) Biobank is a multi-site infrastructure located in the province of Quebec (Canada) to collect, store, and supply high-quality human biological specimens for research on respiratory diseases. The sample types are diverse (plasma, serum, buffy coat, primary lung cells, lung parenchyma, bronchial biopsies, polyps, others), disease-oriented, and mirror research activities  conducted at each site. The biobank currently manages approximately 57,000 specimens from 8,000 research participants or patients treated by standard of care. Specimens’ inventory and corresponding c...
Source: Open Journal of Bioresources - December 31, 2018 Category: Biotechnology Source Type: research

AIDS and Cancer Specimen Resource (ACSR)
The AIDS and Cancer Specimen Resource (ACSR) has four regional biorepositories (RBRs) in the United States and one in South Africa. The ACSR is funded by the National Cancer Institute (NCI) of the National Institutes of Health (United States) to support investigators studying HIV/AIDS and HIV/AIDS-associated malignancies. The ACSR inventory includes more than 450,000 annotated HIV-positive biospecimens from over 10,000 individuals and 100,000 HIV-negative controls from approximately 4,250 individuals, reflecting the pre-highly active antiretroviral therapy (HAART) and post-HAART era of the HIV epidemic, as well as selected...
Source: Open Journal of Bioresources - October 5, 2018 Category: Biotechnology Source Type: research

The Wales Cancer Bank (WCB)
was established in 2004 and consents patients in Wales, UK with a known or suspected cancer diagnosis to donate biosamples for future research. The resource is open access to all researchers working in cancer research, regardless of geographic location or employment sector. To December 2017, just over 13,500 patients have donated samples across a variety of tumour types. Tumour and adjacent normal tissue and blood samples are routinely collected, stored and processed to standardised protocols. Bespoke collections for unique samples such as urine or ascites are also available. Pathology data, clinical data including treatm...
Source: Open Journal of Bioresources - September 18, 2018 Category: Biotechnology Source Type: research

Bioresource of Cervical Tissue Explants from Healthy Women
The York Tissue Bank was established in 2013 at the University of York as a repository for cells and tissues to facilitate clinical and translational research at the university and with collaborative external tissue bank applicants. The bioresource described in this publication was initially established to conduct investigations into infection processes of sexually transmitted diseases inex vivo organotypical models, specifically in uterine cervical tissue. Healthy human uterine cervical tissue is currently available to suitable applicants for ethically approved scientific research meeting the access criteria of the York t...
Source: Open Journal of Bioresources - September 18, 2018 Category: Biotechnology Source Type: research

The Northern Ireland Biobank: A Cancer Focused Repository of Science
The Northern Ireland Biobank (NIB) was established in 2011 as a joint initiative between Queen ’s University Belfast and Belfast Health and Social Care Trust to provide the infrastructure for the standardised collection and storage of high quality, well annotated human tissue samples, with matched bloods and bodily fluids to underpin cancer research in Northern Ireland and beyond. The NIB h as been instrumental in supporting translational research locally, nationally and internationally with a number of key achievements to date. The vision of NIB is to develop an internationally recognised biobank network within Nort...
Source: Open Journal of Bioresources - September 11, 2018 Category: Biotechnology Source Type: research

Dutch Parelsnoer Institute-Cerebrovascular Accident (CVA) Study: A Large Multicenter Clinical Biobank with Standardized Collection and Storage
The Dutch Parelsnoer Institute-Cerebrovascular accident (CVA) Study is part of the Parelsnoer Institute (PSI), initiated in 2007 by the Netherlands Federation of University Medical Centers (NFU). PSI is a cooperation of all eight Dutch University Medical Centers (UMCs) and aims at building large prospectively collected datasets with uniformly and standardized storage of biomaterials for complex diseases. Currently, PSI covers 18 disease-specific cohorts called ‘Pearls’, and this number is still growing. One of these cohorts is the Stroke or CVA Pearl. For each of the cohorts, PSI offers the UMCs an infrastructu...
Source: Open Journal of Bioresources - July 20, 2018 Category: Biotechnology Source Type: research

Hospital-integrated Biobanking as a Service – The Interdisciplinary Bank of Biomaterials and Data Wuerzburg (ibdw)
The ibdw was established in 2011 as one of 5 centralised national biobanks in Germany within the framework of the governmental funding program “Nationale Biobank-Initiative”. The ibdw is a joint core facility of both, the University Hospital and the Julius-Maximilians-University Würzburg and acts as a faculty-wide service provider of human biological material for medical research. From the outset main emphasis was placed on comprehen sive automation and seamless integration of sample collection in clinical routine workflows thereby securing highest quality standards. The ibdw collects fluid and tissue samples...
Source: Open Journal of Bioresources - April 24, 2018 Category: Biotechnology Source Type: research

Bimetra Biobank: A High Quality Biobank Facility to Stimulate Translational Biomedical Research
Bimetra Biobank is the central high quality biorepository of University Hospital Ghent in collaboration with Ghent University (Belgium). Fully operational since 2015 in a new state-of-the-art biobank facility, Bimetra Biobank acts as a core facility for researchers and third parties looking for high-quality annotated clinical biospecimens. Bimetra Biobank stores about 120.000 clinical samples, both historical collections and prospective collections (disease-based collections, population-based collections and basic research collections) within well-defined and ethically approved research projects. Through a clear governance...
Source: Open Journal of Bioresources - April 24, 2018 Category: Biotechnology Source Type: research

Amniotic Fluid Cells Biobank for Research on Fetal Mesenchymal Stem Cells
The research biobank “Anna Maria Ferraro Cutino” AOR-villa Sofia-Cervello, started in 2010 by a grant of the Sicilian Department of Health. Within the biobank are collected, characterized, stored and distributed amniotic fluids (AF) from amniocentesis performed for maternal age. Patients choose to donate to the biob ank the first 3 ml of AF that cannot be used for prenatal diagnosis. AF and donor data are anonymously archived in a database, according to the standard ethical principles. Collateral biobanks are present to collect, storage and manage donor sera and DNA samples, to perform microbiological and genet...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research

The Radboud Biobank: A Central Facility for Disease-Based Biobanks to Optimise Use and Distribution of Biomaterial for Scientific Research in the Radboud University Medical Center, Nijmegen
The Radboud Biobank offers disease-based biobanks a centralized facility to optimize the use and distribution of biomaterial for scientific research. Notably, two population biobanks are also included in this collection. All collections are professionally and sustainably maintained using high-quality and secure standardized protocols for ICT, legal-ethical aspects, sample collection, processing and storage, communication and distribution. The Radboud Biobank includes biomaterial (e.g. DNA, serum, plasma, tissue, urine and faeces – depending on the specific patient group), images, associated clinical data (patient, di...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research

The Tumour Bank at the Children ’s Hospital at Westmead: An Australian Paediatric Cancer Biorepository
In conclusion, the Children’s Hospital at Westmead Tumour Bank has demonstrated a sustained single institutional biorepository model for facilitating translational research of rare cancer. It has provided strong evidence that integration of a single institutional biobank into standard clinical practices would be the long-term pathway of valuable bio-resource for rare cancer research. Published on 2018-02-06 13:29:59 (Source: Open Journal of Bioresources)
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research

Tumorbank@uza: A Collection of Tissue, Fluid Samples and Associated Data of Oncology Patients for the Use in Translational Research
Tumorbank@UZA is an academic hospital integrated biobank that collects tissue, blood and urine samples from oncology patients. We work according to a quality management system and have established SOPs for all work procedures in the biobank. Tumorbank@UZA is funded by the National Cancer Plan, an initiative from the Belgian government since 2009. Samples from our biobank are available for both academic as well as commercial researchers, through a well-established access procedure. Currently the collection consists of more than 85.000 samples of more than 8000 patients. Funding statement:Tumorbank@UZA is funded by the ...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research

The Brisbane Breast Bank
(BBB) was established in 2005 with a view to collecting surplus tissue from every breast surgery patient at the Royal Brisbane and Women ’s Hospital. This not-for-profit biobank provides resources on a collaborative basis, supporting local, national and international studies. The resource prides itself on its comprehensive clinico-pathology sample annotation. Since its inception, the remit of the BBB has expanded to the prospective collection of serial blood samples from patients at high risk of recurrence, and the collection of blood and tumour tissue from metastatic patients. Funding statement:RBWH Foundation...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research

Biobank Graz: The Hub for Innovative Biomedical Research
Biobank Graz was established in 2007 as publicly funded, non-profit central research facility of Medical University of Graz, Austria. Biobank Graz is ISO 9001:2008 certified and stores about 7.5 million samples and their associated data, including formalin fixed paraffin embedded (FFPE) and fresh frozen tissues plus fluid samples (serum, plasma, full blood, urine and cerebrospinal, follicular and seminal fluids, etc.) covering 30 years of collection. Samples are handled and stored in semi or fully automated systems to optimally maintain sample quality and retrieval rates. With its broad informed consent, Biobank Graz distr...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

The SEARCHBreast Portal: A Virtual Bioresource to Facilitate the Sharing of Surplus Animal Materials Derived from Breast Cancer Studies
The SEARCHBreast portal (https://searchbreast.org/) provides access to a virtual bioresource enabling researchers to access and share material derived from breast cancer related animal studies on a collaborative basis. By registering as members of SEARCHBreast, researchers can browse the SEARCHBreast platform for relevant tissue and models, and request access to these to help answer their specific biological question(s). SEARCHBreast mediates the collaborations formed from requests for these materials. As of July 2016, the virtual bioresource has received 8 requests for tissue and has sent hundreds of tissue samples saving...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

The Prostate Cancer Research Consortium Bioresource (Ireland)
The Prostate Cancer Research Consortium (PCRC) is a co-ordinated group of researchers and clinicians from universities and hospitals in Ireland whose aim is to improve the diagnosis and treatment of prostate cancer by engaging in biomarker discovery and validation research. The PCRC has established a prostate cancer bioresource that collects biological samples and comprehensive clinical information collected at time of recruitment and subsequent follow from prostate cancer patients undergoing Transurethral resection of the prostate (benign disease) or radical prostatectomy (indolent, significant and aggressive, Gleason Sco...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

Biobank Lodz – DNA Based Biobank at the University of Lodz, Poland
The Biorepository in Department of Molecular Biophysics of the University of Lodz was established in 2010 as an internal bioresource to collect and store Polish population-based biospecimens. In 2014 biorepository started to act as Biobank Lab of University of Lodz (BLUL/Biobank Lodz). The Biobank Lodz joined the BBMRI_PL (consortium of Polish biobanks) in 2014 and in 2016 BLUL became a member of the BCNet (Biobank and Cohort Building Network) and ESBB (European and Middle Eastern Society for Biopreservation and Biobanking). The BLUL stores over 12.200 samples and their data, including section of formalin fixed paraffin em...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

SDN Biobank: Bioresource of Human Samples Associated with Functional and/or Morphological Bioimaging Results for the Study of Oncological, Cardiological, Neurological, and Metabolic Diseases
SDN Biobank is a not-for-profit service unit. Initially, it was established by the IRCCS SDN in 2012 as a collection of serum and plasma samples from patients who underwent advanced bioimaging exams, such as those performed with Positron Emission Tomography with integrated Magnetic Resonance Imaging (PET/MRI). In July 2015, SDN Biobank was approved by the local ethics committee to collect human samples from patients affected by oncological, cardiological, neurological, and metabolic diseases when performing diagnostic exams at the IRCCS SDN. All samples are coded and associated with clinical and iconographic documentation ...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

Biobank of Cells, Tissues and DNA from Patients with Neuromuscular Diseases: An Indispensable link between Clinical Centers and the Scientific Community
The Biobank was established in 1986 as part of the routine diagnostic activity of the Division of Neuromuscular Diseases and Neuroimmunology, of the Carlo Besta Neurological Institute. It stores muscle tissue, cells and DNA from patients with neuromuscular diseases.The biobank provides samples as a service to the scientific community conducting research on neuromuscular disorders. Samples are from patients affected by different forms of muscular dystrophy, including the severe congenital and Duchenne muscular dystrophies, as well as limb girdle muscular dystrophies, congenital myopathies, distal and myofibrillar myopathies...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands
The Parelsnoer Institute (PSI) is a collaborative biobanking project of all eight University Medical Centers in the Netherlands which was launched in 2007. Basically, PSI consists of three dimensions: participating institutions, disease entities and a central organization. An executive board for operational management instigates collective strategic and tactic policies and a central team of PSI experts and advisors supports the researchers and the board in establishing and implementing standards and procedures. PSI offers researchers an infrastructure and standard procedures for the establishment, expansion and optimisatio...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis
The UK ME/CFS Biobank was launched in August 2011 following extensive consultation with professionals and patient representatives. The bioresource aims to enhance research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), related to pathophysiology, biomarkers and therapeutic approaches. The cohort includes 18 –60 year olds, encompassing 284 clinically-confirmed ME/CFS cases, 60 neurologist-diagnosed multiple sclerosis (MS) cases, and 135 healthy individuals. The Biobank contains blood samples, aliquoted into serum, plasma, peripheral blood mononuclear cells (PBMC), red blood cells/granulocyte pellet, w...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

EGEA Collection: A Biobank Devoted to Asthma and Asthma-related Phenotypes
The Epidemiological study on the Genetics and Environment of Asthma (EGEA) is a 20-year cohort including cases with asthma (n = 388), their first degree relatives (n = 1244) and population-based controls (n = 415) recruited in the early 90 ’s from five French cities. Participants were extensively characterized regarding environment and respiratory health, and a specific effort was made to trace and bank biological samples (ISO 9001 certification since 2006). Access to data and samples is opened to researchers wishing to develop new scientific collaborative programs. The survey has already led to more than a hundred p...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

The UK Clinical Research Collaboration (UKCRC) Tissue Directory and Coordination Centre: The UK ’s Centre for facilitating the Usage of Human Samples for Medical Research
The UKCRC Tissue Directory and Coordination Centre was established to improve access to and utilisation of UK human tissue samples for medical research. The key output of the Centre is the creation of the UK ’s first pan-disease Tissue Directory (https://directory.biobankinguk.org/). Any researcher can search the Directory based on a series of simple key words including disease classification, age, sex, sample type, preservation details, quality indicators and datasets available. The Directory as of April 2017 contains 100 Bioresources. Researchers seeking fresh samples can also search for facilities that offer bespo...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research

EGEA Collection: A Biobank Devoted to Asthma and Asthma-related Phenotypes
The Epidemiological study on the Genetics and Environment of Asthma (EGEA) is a 20-year cohort including cases with asthma (n = 388), their first degree relatives (n = 1244) and population-based controls (n = 415) recruited in the early 90 ’s from five French cities. Participants were extensively characterized regarding environment and respiratory health, and a specific effort was made to trace and bank biological samples (ISO 9001 certification since 2006). Access to data and samples is opened to researchers wishing to develop new scientific collaborative programs. The survey has already led to more than a hundred p...
Source: Open Journal of Bioresources - April 4, 2017 Category: Biotechnology Source Type: research

The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis
The UK ME/CFS Biobank was launched in August 2011 following extensive consultation with professionals and patient representatives. The bioresource aims to enhance research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), related to pathophysiology, biomarkers and therapeutic approaches. The cohort includes 18 –60 year olds, encompassing 284 clinically-confirmed ME/CFS cases, 60 neurologist-diagnosed multiple sclerosis (MS) cases, and 135 healthy individuals. The Biobank contains blood samples, aliquoted into serum, plasma, peripheral blood mononuclear cells (PBMC), red blood cells/granulocyte pellet, w...
Source: Open Journal of Bioresources - February 20, 2017 Category: Biotechnology Source Type: research

The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands
The Parelsnoer Institute (PSI) is a collaborative biobanking project of all eight University Medical Centers in the Netherlands which was launched in 2007. Basically, PSI consists of three dimensions: participating institutions, disease entities and a central organization. An executive board for operational management instigates collective strategic and tactic policies and a central team of PSI experts and advisors supports the researchers and the board in establishing and implementing standards and procedures. PSI offers researchers an infrastructure and standard procedures for the establishment, expansion and optimisatio...
Source: Open Journal of Bioresources - February 18, 2017 Category: Biotechnology Source Type: research

SDN Biobank: Bioresource of Human Samples Associated with Functional and/or Morphological Bioimaging Results for the Study of Oncological, Cardiological, Neurological, and Metabolic Diseases
SDN Biobank is a not-for-profit service unit. Initially, it was established by the IRCCS SDN in 2012 as a collection of serum and plasma samples from patients who underwent advanced bioimaging exams, such as those performed with Positron Emission Tomography with integrated Magnetic Resonance Imaging (PET/MRI). In July 2015, SDN Biobank was approved by the local ethics committee to collect human samples from patients affected by oncological, cardiological, neurological, and metabolic diseases when performing diagnostic exams at the IRCCS SDN. All samples are coded and associated with clinical and iconographic documentation ...
Source: Open Journal of Bioresources - February 13, 2017 Category: Biotechnology Source Type: research

Biobank of Cells, Tissues and DNA from Patients with Neuromuscular Diseases: An Indispensable link between Clinical Centers and the Scientific Community
The Biobank was established in 1986 as part of the routine diagnostic activity of the Division of Neuromuscular Diseases and Neuroimmunology, of the Carlo Besta Neurological Institute. It stores muscle tissue, cells and DNA from patients with neuromuscular diseases.The biobank provides samples as a service to the scientific community conducting research on neuromuscular disorders. Samples are from patients affected by different forms of muscular dystrophy, including the severe congenital and Duchenne muscular dystrophies, as well as limb girdle muscular dystrophies, congenital myopathies, distal and myofibrillar myopathies...
Source: Open Journal of Bioresources - February 13, 2017 Category: Biotechnology Source Type: research

Biobank Lodz – DNA Based Biobank at the University of Lodz, Poland
The Biorepository in Department of Molecular Biophysics of the University of Lodz was established in 2010 as an internal bioresource to collect and store Polish population-based biospecimens. In 2014 biorepository started to act as Biobank Lab of University of Lodz (BLUL/Biobank Lodz). The Biobank Lodz joined the BBMRI_PL (consortium of Polish biobanks) in 2014 and in 2016 BLUL became a member of the BCNet (Biobank and Cohort Building Network) and ESBB (European and Middle Eastern Society for Biopreservation and Biobanking). The BLUL stores over 12.200 samples and their data, including section of formalin fixed paraffin em...
Source: Open Journal of Bioresources - December 1, 2016 Category: Biotechnology Source Type: research

The Prostate Cancer Research Consortium Bioresource (Ireland)
The Prostate Cancer Research Consortium (PCRC) is a co-ordinated group of researchers and clinicians from universities and hospitals in Ireland whose aim is to improve the diagnosis and treatment of prostate cancer by engaging in biomarker discovery and validation research. The PCRC has established a prostate cancer bioresource that collects biological samples and comprehensive clinical information collected at time of recruitment and subsequent follow from prostate cancer patients undergoing Transurethral resection of the prostate (benign disease) or radical prostatectomy (indolent, significant and aggressive, Gleason Sco...
Source: Open Journal of Bioresources - November 16, 2016 Category: Biotechnology Source Type: research

Biobank Graz: The Hub for Innovative Biomedical Research
Biobank Graz was established in 2007 as publicly funded, non-profit central research facility of Medical University of Graz, Austria. Biobank Graz is ISO 9001:2008 certified and stores about 7.5 million samples and their associated data, including formalin fixed paraffin embedded (FFPE) and fresh frozen tissues plus fluid samples (serum, plasma, full blood, urine and cerebrospinal, follicular and seminal fluids, etc.) covering 30 years of collection. Samples are handled and stored in semi or fully automated systems to optimally maintain sample quality and retrieval rates. With its broad informed consent, Biobank Graz distr...
Source: Open Journal of Bioresources - July 22, 2016 Category: Biotechnology Source Type: research

The SEARCHBreast Portal: A Virtual Bioresource to Facilitate the Sharing of Surplus Animal Materials Derived from Breast Cancer Studies
The SEARCHBreast portal ( https://searchbreast.org/ ) provides access to a virtual bioresource enabling researchers to access and share material derived from breast cancer related animal studies on a collaborative basis. By registering as members of SEARCHBreast, researchers can browse the SEARCHBreast platform for relevant tissue and models, and request access to these to help answer their specific biological question(s). SEARCHBreast mediates the collaborations formed from requests for these materials. As of July 2016, the virtual bioresource has received 8 requests for tissue and has sent hundreds of tissue samples savi...
Source: Open Journal of Bioresources - July 22, 2016 Category: Biotechnology Source Type: research

Biobank of Psychiatric Diseases Mannheim – BioPsy
High quality biomaterial from patients and controls is a core prerequisite for research into the biological causes of mental disorder. BioPsy is the biobank of the Department of Genetic Epidemiology in Psychiatry at the Central Institute of Mental Health in Mannheim, Germany, and one of the largest psychiatric disorder biobanks worldwide. Here, ongoing collection is in progress for blood, DNA, mRNA, plasma, serum, saliva, urine, hair, and other biomaterials. Reuse of samples is permitted in a collaboration-based context. BioPsy operates according to German and European quality and data privacy standards. Published on 2016-...
Source: Open Journal of Bioresources - July 8, 2016 Category: Biotechnology Source Type: research

Galliera Genetic Bank: A DNA and Cell Line Biobank from Patients Affected by Genetic Diseases
The Galliera Genetic Bank is part of the Laboratory of Human Genetics of Galliera Hospital in Genoa and has collected samples from patients affected by genetic diseases since 1983. Presently, it stores 10,259 biospecimens and associated data from about 200 genetic disorders. The most representative disorders are chromosome disorders (Down s., Ring chromosome 14 s., Cri du chat s. and Isodicentric 15 chromosome), neurological diseases (Fragile X s., Mowat Wilson s. and Dravet s.), rare bone diseases (Crouzon s., Achondroplasia, Grieg s. and Thanathophoric dwarfism), overgrowth syndromes (Sotos s.), familial hypertrophic car...
Source: Open Journal of Bioresources - April 27, 2016 Category: Biotechnology Source Type: research

The Australian Breast Cancer Tissue Bank (ABCTB)
The ABCTB was established in 2006 as an open access, not for profit resource dedicated to providing biospecimens and/or data to both national and international research projects in the field of breast cancer. Donors are consented according to standard ethical principles for use of their material for unspecified future research. ABCTB collects fully annotated clinical samples and associated clinical and longitudinal data from donors. Material and data is supplied to research projects. Published on 2014-07-24 08:41:49 (Source: Open Journal of Bioresources)
Source: Open Journal of Bioresources - February 10, 2016 Category: Biotechnology Source Type: research

Cell Line and DNA Biobank From Patients Affected by Genetic Diseases
The Bioresource, presently storing 10,279 biospecimens, was initially established in 1976 as a private laboratory-collection to maintain rare mutant cell lines from genetic-metabolic diseases. Shortly afterwards, however, data from the sample collection was organised in a database and the sample collection was released to the scientific community. The Biobank has received Telethon grants since 1993, as individual facility, and from 2008 as part of the Telethon Network of Genetic Biobanks (www.biobanknetwork.org).In 2010, the Biobank has obtained official recognition from Regione Liguria. The Biobank has always provided ess...
Source: Open Journal of Bioresources - February 10, 2016 Category: Biotechnology Source Type: research

Bioresource from the French Gazel Cohort Study
The GAZEL Cohort Study set up in 1989 is a general-purpose epidemiologic cohort. At inception in 1989, the cohort included 20,625 volunteers then aged from 35-50 (women; n= 5,614) or 40-50 (men; n= 15,011). The data collected routinely come from different sources, mainly annual self-administered questionnaires, socioeconomic and health administrative data, health examinations, and causes of death. The epidemiologic database is maintained and stored by our group in our own facilities; the biobank is stored in the “Centre de ressources biologiques”, in Dijon, France. Today, more than 50 epidemiological projects o...
Source: Open Journal of Bioresources - February 10, 2016 Category: Biotechnology Source Type: research

Urolithiasis Bioresource
Urolithiasis is frequent and raises significant health care burden in a working-age population. Its prevalence, in the Azores archipelago, is currently unknown but it is thought to be higher than the overall estimated prevalence. The Azores Biobank (AZORBIO) Urolithiasis samples have been collected in accordance with standard operation procedures (SOPs) to ensure high quality. Each donor provided 30 ml whole blood and 9 ml of urine. If possible, we preferred blood collected from fasting individuals and first morning urine samples. Aliquots of plasma, serum, DNA, RNA and urine, are stored at -80°C freezers. This collect...
Source: Open Journal of Bioresources - February 10, 2016 Category: Biotechnology Source Type: research

Public Oncologic Serum biobank
The Public Oncologic Serum Biobank is a not for-profit organization that has been established within the academia setting since 2009, which aims to prospectively collect and store serum samples from cancer patients and volunteers and their associated clinical and epidemiological data, with the ultimate goal to distribute them to the local and international research community focusing in understanding and improving cancer diagnosis and treatment. Published on 2014-10-07 08:58:52 (Source: Open Journal of Bioresources)
Source: Open Journal of Bioresources - February 10, 2016 Category: Biotechnology Source Type: research

The Multispecialistic da Vinci European BioBank
The da Vinci European BioBank (daVEB) is a research infrastructure established in 2009 in the Scientific Campus of the University of Florence (Sesto Fiorentino, Italy) belonging to the non-profit foundation FiorGen, which promotes studies aimed at exploiting knowledge on human health. Since 2011, daVEB is ISO9001 certified for collection, storage and distribution of biological samples and the associated data for scientific research. The biobank is currently storing about 9.000 biospecimens (serum, plasma, white cells, tissue, DNA, cells and urine) collected according to specific informed consents by Research Units from hea...
Source: Open Journal of Bioresources - February 10, 2016 Category: Biotechnology Source Type: research

Genomic and Genetic Disorders Biobank
The Genomic and Genetic Disorders Biobank (GGDB, formerly Genomic Disorders Biobank) was established in 2006 as an internal bioresource supported by own database, to collect and store biospecimens from genomic-disorder (e.g. microdeletion and duplication syndromes) affected individuals. Since 2009 the Bioresource has joined the Telethon Network of Genetic Biobanks and has expanded the collection to include also genetic mendelian diseases. The GGDB gathers wholly annotated clinical and longitudinal data and biological samples from affected and healthy donors, according to standard ethical principles. Biospecimens are availa...
Source: Open Journal of Bioresources - February 10, 2016 Category: Biotechnology Source Type: research